| Laurel Helene Desnick, MD | |
|
1001 River Dr, Livingston, MT 59047-3716 | |
| (406) 222-0800 | |
| (406) 222-7606 |
| Full Name | Laurel Helene Desnick |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1001 River Dr, Livingston, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841376639 | NPI | - | NPPES |
| 8247553 | Medicaid | WA | |
| 4575 | Other | INTERNAL ID-MOTOR VEHICLE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD00036360 (Washington) | Secondary |
| 207R00000X | Internal Medicine | 620316 (Montana) | Primary |
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20031122000111 |
News Archive
Actavis Group, an international generic pharmaceuticals company, today announced that it recently received approval from the US Food & Drug Administration to market Methylphenidate Hydrochloride Extended-Release Capsules (LA) CII, USP, 20mg, 30mg, and 40mg. Actavis has first-to-file exclusivity on the 20mg, 30mg, and 40mg strengths.
ResCare, Inc. announced today that it has received a proposal from Onex Corporation to acquire all of the outstanding shares of common stock of ResCare not owned by affiliates of Onex for $12.60 per share. The written proposal, which includes several terms and conditions, is attached to this release.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
Borrowing a Republican idea, a group including former senior Obama and Clinton advisers is unveiling a novel proposal to let states take the lead in controlling health costs.
› Verified 2 days ago
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20061104000158 |
News Archive
Actavis Group, an international generic pharmaceuticals company, today announced that it recently received approval from the US Food & Drug Administration to market Methylphenidate Hydrochloride Extended-Release Capsules (LA) CII, USP, 20mg, 30mg, and 40mg. Actavis has first-to-file exclusivity on the 20mg, 30mg, and 40mg strengths.
ResCare, Inc. announced today that it has received a proposal from Onex Corporation to acquire all of the outstanding shares of common stock of ResCare not owned by affiliates of Onex for $12.60 per share. The written proposal, which includes several terms and conditions, is attached to this release.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
Borrowing a Republican idea, a group including former senior Obama and Clinton advisers is unveiling a novel proposal to let states take the lead in controlling health costs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laurel Helene Desnick, MD 504 S 13th St, Livingston, MT 59047-3727 Ph: (406) 823-6414 | Laurel Helene Desnick, MD 1001 River Dr, Livingston, MT 59047-3716 Ph: (406) 222-0800 |
News Archive
Actavis Group, an international generic pharmaceuticals company, today announced that it recently received approval from the US Food & Drug Administration to market Methylphenidate Hydrochloride Extended-Release Capsules (LA) CII, USP, 20mg, 30mg, and 40mg. Actavis has first-to-file exclusivity on the 20mg, 30mg, and 40mg strengths.
ResCare, Inc. announced today that it has received a proposal from Onex Corporation to acquire all of the outstanding shares of common stock of ResCare not owned by affiliates of Onex for $12.60 per share. The written proposal, which includes several terms and conditions, is attached to this release.
Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.
Borrowing a Republican idea, a group including former senior Obama and Clinton advisers is unveiling a novel proposal to let states take the lead in controlling health costs.
› Verified 2 days ago
James Thomas Rowe, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 504 S 13th St, Livingston, MT 59047 Phone: 406-222-3541 Fax: 406-222-5087 | |
Dr. Henry Pinango, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 406-222-3541 Fax: 406-222-7606 | |
Ted R Scofield, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Alpenglow Lane, Livingston, MT 59047 Phone: 406-823-6414 Fax: 406-823-6287 | |
Douglas P Wadle, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Alpenglow Lane, Livingston, MT 59047 Phone: 406-823-6414 Fax: 406-823-6287 |